DNA methylation and systemic lupus erythematosus

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 127-136

  Balada, Eva ^a   Ordi Ros, Josep ^a   Vilardell Tarrés, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

DNA methylation; Systemic lupus erythematosus; T cells

Indexed keywords

DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 4; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONFERENCE PAPER; CORRELATION ANALYSIS; DNA METHYLATION; ENZYME ANALYSIS; EPIGENETICS; GENE EXPRESSION; HUMAN; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 34948906784     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.015     Document Type: Conference Paper

References (42)

1. RAZIN, A. & A. D. RIGGS. 1980. DNA methylation and gene function. Science 210: 604-610.
2. JONES, P. A. & S.M. TAYLOR. 1980. Cellular differentiation, cytidine analogs and DNA methylation. Cell 20: 85-93.
3. LI, E. 1997. Role of DNA methylation in development. In Genomic Imprinting: Frontiers in Molecular Biology. W. REIK and A. SURANI, Eds.: 1-20. IRL Press. Oxford.
4. JÄHNER, D. & R., JAENISCH. 1984. DNA methylation in early mammalian development. In DNA methylation: Biochemistry and Biological Significance. A. RAZIN, H. CEDAR & A. RIGGS, Eds.: Springer-Verlag. New York.
5. BROCKDORFF, N. 1997. Convergent themes in X chromosome inactivation and autosomal imprinting. In Genomic Imprinting: Frontiers in Molecular Biology. W. REIK & A. SURANI, Eds.: 191-210. IRL Press. Oxford.
6. SURANI, M. A. 1998. Imprinting and the initiation of gene silencing in the germ line. Cell 93: 309-312.
7. NG, H. H. & A. BIRD. 1999. DNA methylation and chromatin modification. Curr. Opin. Genet. Dev. 9: 158-163.
8. JONES, P. A. & P. W. LAIRD. 1999. Cancer epigenetics comes of age. Nat. Genet. 21: 163-167.
9. CORNACCHIA, E., J. GOLBUS, J. MAYBAUM, et al. 1988. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 140: 2197-2200.
10. RICHARDSON, B., D. POWERS, F. HOOPER, et al. 1994. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum. 37: 1363-1372.
11. YUNG, R., S. CHANG, N. HEMATI, et al. 1997. Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. Arthritis Rheum. 40: 1436-1443.
12. RICHARDSON, B., L. SCHEINBART, J. STRAHLER, et al. 1990. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 33: 1665-1673.
13. RICHARDSON, B. C., J. R. STRAHLER, T.S. PIVIROTTO, et al. 1992. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum. 35: 647-662.
14. TAKEUCHI, T., K. AMANO, H. SEKINE, et al. 1993. Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. J. Clin. Invest. 92: 3008-3016.
15. MIZUGAKI, M., T. YAMAGUCHI, S. ISHIWATA, et al. 1997. Alteration of DNA methylation levels in MRL lupus mice. Clin. Exp. Immunol. 110: 265-269.
16. QUDDUS, J., K. J. JOHNSON, J. GAVALCHIN, et al. 1993. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92: 38-53.
17. DAHL, C. & P. GULDBERG. 2003. DNA methylation analysis techniques. Biogerontology 4: 233-250.
18. OAKELEY, E. J., A. PODESTA & J.P. JOST. 1997. Developmental changes in DNA methylation of the two tobacco pollen nuclei during maturation. Proc. Natl. Acad. Sci. USA 94: 11721-11725.
19. MIZUGAKI, M., K. ITOH, T. YAMAGUCHI, et al. 1996. Preparation of a monoclonal antibody specific for 5-methyl-2′-deoxycytidine and its application for the detection of DNA methylation levels in human peripheral blood cells. Biol. Pharm. Bull. 19: 1537-1540.
20. DENG, C., M. J. KAPLAN, J. YANG, et al. 2001. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 44: 397-407.
21. OKANO, M., D. W. BELL, D. A. HABER, et al. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.
22. OKANO, M., S. XIE & E. LI. 1998. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19: 219-220.
23. OGASAWARA, H., M. OKADA, H. KANEKO, et al. 2003. Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. Clin. Exp. Rheumatol. 21: 733-738.
24. BHATTACHARYA, S. K., S. RAMCHANDANI, N. CERVONI, et al. 1999. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397: 579-583.
25. HENDRICH, B. & A. BIRD. 1998. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18: 6538-6547.
26. HENDRICH, B., U. HARDELAND, H. H. NG, et al. 1999. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401: 301-304.
27. ZHU, B., Y. ZHENG, H. ANGLIKER, et al. 2000. 5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence. Nucleic Acids Res. 28: 4157-4165.
28. CÖR, A. 2000. The relationship between DNA methylation and expression of three different DNA methyltransferases in ovarian cancer. Radiol. Oncol. 34: 369-374.
29. YANG, J., C. DENG, N. HEMATI, et al. 1997. Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. J. Immunol. 159: 1303-1309.
30. CHRISTMAN, J. K., G. SHEIKHNEJAD, M. DIZIK, et al. 1993. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 14: 551-557.
31. SLACK, A., N. CERVONI, M. PINARD, et al. 1999. Feedback regulation of DNA methyltransferase gene expression by methylation. Eur. J. Biochem. 264: 191-199.
32. YODER, J. A., N. S. SOMAN, G. L. VERDINE, et al. 1997. DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J. Mol. Biol. 270: 385-395.
33. NG, H. H., Y. ZHANG, B. HENDRICH, et al. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23: 58-61.
34. DETICH, N., J. THEBERGE & M. SZYF. 2002. Promoter-specific activation and demethylation by MBD2/demethylase. J. Biol. Chem. 277: 35791-35794.
35. VILAIN, A., N. VOGT, B. DUTRILLAUX, et al. 1999. DNA methylation and chromosome instability in breast cancer cell lines. FEBS Lett. 460: 231-234.
36. WILSON, C. B., K. W. MAKAR, M. SHNYREVA, et al. 2005. DNA methylation and the expanding epigenetics of T cell lineage commitment. Semin. Immunol. 17: 105-119.
37. LU, Q., M. KAPLAN, D. RAY, et al. 2002. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 46: 1282-1291.
38. KAPLAN, M. J., Q. LU, A. WU, et al. 2004. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 172: 3652-3661.
39. OELKE, K., Q. LU, D. RICHARDSON, et al. 2004. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 50: 1850-1860.
40. HUTCHINS, A. S., D. ARTIS, B. D. HENDRICH, et al. 2005. Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunity. J. Immunol. 175: 5606-5610.
41. SANSOM, O. J., J. ZABKIEWICZ, S.M. BISHOP, et al. 2003. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene 22: 7130-7136.
42. SCREATON, R. A., S. KIESSLING, O. J. SANSOM, et al. 2003. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc. Natl. Acad. Sci. USA 100: 5211-5216.